Assembly Biosciences Inc (ASMB)
17.05
+0.35
(+2.10%)
USD |
NASDAQ |
Nov 14, 16:00
16.79
-0.26
(-1.52%)
After-Hours: 20:00
Assembly Biosciences Cash from Investing (Quarterly): 5.107M for June 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 5.107M |
| March 31, 2024 | 17.27M |
| December 31, 2023 | -89.65M |
| September 30, 2023 | 18.88M |
| June 30, 2023 | -8.365M |
| March 31, 2023 | 10.00M |
| December 31, 2022 | 16.56M |
| September 30, 2022 | 31.43M |
| June 30, 2022 | 9.597M |
| March 31, 2022 | 33.05M |
| December 31, 2021 | -8.484M |
| September 30, 2021 | 20.07M |
| June 30, 2021 | -3.087M |
| March 31, 2021 | 18.02M |
| December 31, 2020 | 20.72M |
| September 30, 2020 | -49.89M |
| June 30, 2020 | 76.55M |
| March 31, 2020 | 20.69M |
| December 31, 2019 | -95.02M |
| September 30, 2019 | 7.819M |
| June 30, 2019 | 25.45M |
| March 31, 2019 | 11.44M |
| December 31, 2018 | -62.16M |
| September 30, 2018 | -73.60M |
| June 30, 2018 | 1.462M |
| Date | Value |
|---|---|
| March 31, 2018 | -1.10M |
| December 31, 2017 | -1.673M |
| September 30, 2017 | -1.511M |
| June 30, 2017 | -19.12M |
| March 31, 2017 | 6.658M |
| December 31, 2016 | 15.67M |
| September 30, 2016 | 11.32M |
| June 30, 2016 | 6.714M |
| March 31, 2016 | 2.498M |
| December 31, 2015 | -3.839M |
| September 30, 2015 | -12.19M |
| June 30, 2015 | -48.80M |
| March 31, 2015 | -0.0307M |
| December 31, 2014 | -0.2114M |
| September 30, 2014 | 0.4914M |
| June 30, 2014 | 0.00 |
| March 31, 2014 | -0.0026M |
| December 31, 2013 | -0.0013M |
| September 30, 2013 | 0.00 |
| June 30, 2013 | -0.0052M |
| March 31, 2013 | 0.00 |
| December 31, 2012 | -0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | -0.0032M |
| March 31, 2012 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-95.02M
Minimum
Dec 2019
76.55M
Maximum
Jun 2020
2.286M
Average
16.56M
Median
Dec 2022
Cash from Investing (Quarterly) Benchmarks
| ADMA Biologics Inc | -1.098M |
| Sensus Healthcare Inc | -0.003M |
| Protagonist Therapeutics Inc | -208.71M |
| Precision BioSciences Inc | -0.064M |
| Entrada Therapeutics Inc | -82.93M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -17.10M |
| Cash from Financing (Quarterly) | 12.45M |
| Free Cash Flow | 24.10M |
| Free Cash Flow Per Share (Quarterly) | -3.033 |
| Free Cash Flow to Equity (Quarterly) | -17.12M |
| Free Cash Flow to Firm (Quarterly) | -17.12M |
| Free Cash Flow Yield | 27.14% |